Longitudinal analysis of peripheral and intrahepatic NK cells in chronic HCV patients during antiviral therapy.

[1]  R. D. de Knegt,et al.  The Intrahepatic T Cell Compartment Does Not Normalize Years After Therapy-Induced Hepatitis C Virus Eradication. , 2015, The Journal of infectious diseases.

[2]  A. Boonstra,et al.  IFN‐λ‐mediated IL‐12 production in macrophages induces IFN‐γ production in human NK cells , 2015, European journal of immunology.

[3]  M. Manns,et al.  Compromised function of natural killer cells in acute and chronic viral hepatitis. , 2014, The Journal of infectious diseases.

[4]  M. Manns,et al.  PEG-IFN Alpha but Not Ribavirin Alters NK Cell Phenotype and Function in Patients with Chronic Hepatitis C , 2014, PloS one.

[5]  A. Boonstra,et al.  Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg‐negative chronic hepatitis B , 2014, Liver international : official journal of the International Association for the Study of the Liver.

[6]  C. Tinelli,et al.  Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infection. , 2013, Journal of hepatology.

[7]  E. Wang,et al.  The paradox of NKp46+ natural killer cells: drivers of severe hepatitis C virus-induced pathology but in-vivo resistance to interferon α treatment , 2013, Gut.

[8]  R. D. de Knegt,et al.  Natural killer cell activity and function in chronic HCV-infected patients during peg interferon and ribavirin: early effects of active substance use. , 2013, Antiviral research.

[9]  M. Manns,et al.  Interferon α-stimulated natural killer cells from patients with acute hepatitis C virus (HCV) infection recognize HCV-infected and uninfected hepatoma cells via DNAX accessory molecule-1. , 2012, The Journal of infectious diseases.

[10]  T. Liang,et al.  Early changes in interferon signaling define natural killer cell response and refractoriness to interferon‐based therapy of hepatitis C patients , 2012, Hepatology.

[11]  Milton W. Taylor,et al.  Natural killer inhibitory receptor expression associated with treatment failure and interleukin‐28B genotype in patients with chronic hepatitis C , 2011, Hepatology.

[12]  T. Liang,et al.  Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C. , 2011, Gastroenterology.

[13]  R. D. de Knegt,et al.  Retention of CD4+ CD25+ FoxP3+ Regulatory T Cells in the Liver after Therapy-Induced Hepatitis C Virus Eradication in Humans , 2011, Journal of Virology.

[14]  H. Janssen,et al.  Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. , 2011, Journal of hepatology.

[15]  J. Hoofnagle,et al.  Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. , 2010, Gastroenterology.

[16]  G. Michelone,et al.  Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. , 2009, Gastroenterology.

[17]  N. Hayashi,et al.  Negative Regulation of NK Cell Activities by Inhibitory Receptor CD94/NKG2A Leads to Altered NK Cell-Induced Modulation of Dendritic Cell Functions in Chronic Hepatitis C Virus Infection1 , 2004, The Journal of Immunology.

[18]  Christine A. Biron,et al.  Coordinated and Distinct Roles for IFN-αβ, IL-12, and IL-15 Regulation of NK Cell Responses to Viral Infection1 , 2002, The Journal of Immunology.